SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0000945621-12-000286
Filing Date
2012-12-19
Accepted
2012-12-19 14:37:06
Documents
1
Period of Report
2012-12-14

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4/A  
1 PRIMARY DOCUMENT primary_doc.xml 4/A 6086
  Complete submission text file 0000945621-12-000286.txt   8006
Mailing Address 4673 CHRISTOPHER PLACE DALLAS TX 75204
Business Address
AUSTIN JOSIAH T (Reporting) CIK: 0000932267 (see all company filings)

Type: 4/A | Act: 34 | File No.: 000-51462 | Film No.: 121274020

Mailing Address 4673 CHRISTOPHER PLACE DALLAS TX 75204
Business Address 4673 CHRISTOPHER PLACE DALLAS TX 75204 214-520-1684
El Coronado Holdings, LLC (Reporting) CIK: 0001319763 (see all company filings)

State of Incorp.: AZ | Fiscal Year End: 1231
Type: 4/A | Act: 34 | File No.: 000-51462 | Film No.: 121274019

Mailing Address 3530 TORINGDON WAY SUITE 200 CHARLOTTE NC 28277
Business Address 3530 TORINGDON WAY SUITE 200 CHARLOTTE NC 28277 704-341-1516
Chelsea Therapeutics International, Ltd. (Issuer) CIK: 0001333763 (see all company filings)

IRS No.: 203174202 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)